drugset / Trial / NCT06808295

Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients

NCT06808295

Phase 1 Recruiting 24 enrolled Research Institute of Ophthalmology, Egypt
RandomizedParallel-groupSingle-blindOther

Summary

Assessing the intra and postoperative hemodynamic stability in patients undergoing external dacrocystorhinostomy under general anesthesia using Dexmedetomidine as a preoperative sedation compared to traditional technique with intraoperative analgesia and assessing decreased anesthetic requirements intra and postoperative

Timeline

Start
2024-04-16
Primary completion
2025-04-20
Completion
2025-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.25 ug/kg